CN1242993C - 杂环衍生物和药物 - Google Patents

杂环衍生物和药物 Download PDF

Info

Publication number
CN1242993C
CN1242993C CNB018075347A CN01807534A CN1242993C CN 1242993 C CN1242993 C CN 1242993C CN B018075347 A CNB018075347 A CN B018075347A CN 01807534 A CN01807534 A CN 01807534A CN 1242993 C CN1242993 C CN 1242993C
Authority
CN
China
Prior art keywords
compound
group
alkyl
alkoxy
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB018075347A
Other languages
English (en)
Chinese (zh)
Other versions
CN1422255A (zh
Inventor
冈野昌彦
森和哉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shinyaku Co Ltd
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of CN1422255A publication Critical patent/CN1422255A/zh
Application granted granted Critical
Publication of CN1242993C publication Critical patent/CN1242993C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CNB018075347A 2000-03-31 2001-03-30 杂环衍生物和药物 Expired - Fee Related CN1242993C (zh)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP2000098874 2000-03-31
JP98874/2000 2000-03-31
JP98874/00 2000-03-31
JP336464/00 2000-11-02
JP336464/2000 2000-11-02
JP2000336464 2000-11-02

Publications (2)

Publication Number Publication Date
CN1422255A CN1422255A (zh) 2003-06-04
CN1242993C true CN1242993C (zh) 2006-02-22

Family

ID=26589216

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB018075347A Expired - Fee Related CN1242993C (zh) 2000-03-31 2001-03-30 杂环衍生物和药物

Country Status (10)

Country Link
US (1) US6794389B2 (enExample)
EP (1) EP1306372B1 (enExample)
KR (1) KR20020083533A (enExample)
CN (1) CN1242993C (enExample)
AT (1) ATE449084T1 (enExample)
AU (1) AU2001244688A1 (enExample)
CA (1) CA2403605A1 (enExample)
DE (1) DE60140545D1 (enExample)
RU (1) RU2268260C2 (enExample)
WO (1) WO2001072710A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2422560A1 (en) * 2000-09-20 2002-03-28 Merck Patent Gesellschaft Mit Beschraenkter Haftung 4-amino-quinazolines
ATE383860T1 (de) 2000-11-02 2008-02-15 Nippon Shinyaku Co Ltd Chinazolinderivate und -arzneimittel
KR20030085005A (ko) * 2001-03-19 2003-11-01 니뽄 신야쿠 가부시키가이샤 진양제
US6907295B2 (en) * 2001-08-31 2005-06-14 Biocontrol Medical Ltd. Electrode assembly for nerve control
US7829566B2 (en) * 2001-09-17 2010-11-09 Werner Mederski 4-amino-quinazolines
WO2003091224A1 (en) 2002-04-26 2003-11-06 Nippon Shinyaku Co., Ltd. Quinazoline derivative and medicine
JP4805234B2 (ja) * 2002-12-16 2011-11-02 キッセイ薬品工業株式会社 経口固形医薬
US8309562B2 (en) 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
CN1984660B (zh) 2003-07-03 2010-12-15 美瑞德生物工程公司 作为天冬氨酸特异性半胱氨酸蛋白酶活化剂和细胞程序死亡诱导剂的4-芳基氨基-喹唑啉
CA2553969A1 (en) * 2004-01-23 2005-08-04 Amgen Inc. Vanilloid receptor ligands and their use in treatments
EP1833482A4 (en) 2005-01-03 2011-02-16 Myriad Genetics Inc COMPOUNDS AND ITS THERAPEUTIC USE
US8258145B2 (en) 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
US8431586B2 (en) * 2005-10-03 2013-04-30 Nippon Shinyaku Co., Ltd. Quinazoline derivatives and pharmaceutical compositions thereof
RU2314295C2 (ru) * 2006-03-01 2008-01-10 Федеральное Государственное Образовательное Учреждение Высшего Профессионального Образования "Южный Федеральный Университет" 2-гетарилзамещенные 1,3-трополона, способ их получения (варианты) и фармацевтическая композиция антимикробного действия
AU2008249745B2 (en) * 2007-05-09 2012-01-12 Pfizer Inc. Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials
EP2017294A1 (de) 2007-07-16 2009-01-21 Sika Technology AG Hitzehärtender Schaum
CA2748491C (en) 2008-12-30 2019-08-06 Arqule, Inc. Substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds
US8609672B2 (en) 2010-08-27 2013-12-17 University Of The Pacific Piperazinylpyrimidine analogues as protein kinase inhibitors
RU2576623C2 (ru) 2011-12-28 2016-03-10 Фуджифилм Корпорэйшн Новое производное никотинамида или его соль
CA3180317A1 (en) 2020-04-17 2021-10-21 The Trustees Of Indiana University Small molecule antiviral drug treatment for human papillomavirus infections
US20240425493A1 (en) * 2023-06-13 2024-12-26 The Trustees Of Indiana University Small molecule antiviral drug treatment for human papillomavirus infections

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3753981A (en) * 1970-07-15 1973-08-21 Squibb & Sons Inc 4-amino-2-styrylquinazoline compounds
PT100905A (pt) 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
JP2657760B2 (ja) 1992-07-15 1997-09-24 小野薬品工業株式会社 ４−アミノキナゾリン誘導体およびそれを含有する医薬品
AU7692696A (en) 1995-12-01 1997-06-27 Novartis Ag Heteroaryl derivatives
AU4988997A (en) 1996-10-23 1998-05-15 Osteoscreen, Inc. Compositions and methods for treating bone deficit conditions
CA2226058C (en) 1997-01-30 2008-01-29 F. Hoffmann-La Roche Ag 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives
AR012634A1 (es) 1997-05-02 2000-11-08 Sugen Inc Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion
AU732329B2 (en) 1997-05-30 2001-04-12 Banyu Pharmaceutical Co., Ltd. 2-oxoimidazole derivative
WO1999009986A1 (en) 1997-08-22 1999-03-04 Kyowa Hakko Kogyo Co., Ltd. 4-aminoquinazoline derivatives
TR200003598T2 (tr) 1998-03-26 2001-06-21 Japan Tobacco Inc. Amid türevleri ve nosiseptin antagonistleri
KR20030085005A (ko) 2001-03-19 2003-11-01 니뽄 신야쿠 가부시키가이샤 진양제

Also Published As

Publication number Publication date
EP1306372B1 (en) 2009-11-18
ATE449084T1 (de) 2009-12-15
US6794389B2 (en) 2004-09-21
RU2268260C2 (ru) 2006-01-20
CN1422255A (zh) 2003-06-04
KR20020083533A (ko) 2002-11-02
EP1306372A1 (en) 2003-05-02
CA2403605A1 (en) 2002-09-18
DE60140545D1 (enExample) 2009-12-31
AU2001244688A1 (en) 2001-10-08
EP1306372A4 (en) 2004-03-17
WO2001072710A1 (en) 2001-10-04
US20030119855A1 (en) 2003-06-26
RU2002129100A (ru) 2004-02-27

Similar Documents

Publication Publication Date Title
CN1242993C (zh) 杂环衍生物和药物
CN1043639C (zh) 新的哌啶化合物、其制备方法和含有它们的药用组合物
CN1049217C (zh) 1,5－苯并二氮杂䓬衍生物及其制法以及含它们的药用组合物
CN1078889C (zh) 非肽类速激肽受体拮抗剂
CN1128139C (zh) 新哌嗪衍生物及其制造方法
CN1117077C (zh) 用作nos抑制剂的6－苯基吡啶基－2－胺衍生物
CN1142912C (zh) 用作细胞因子产生的抑制剂的酰胺衍生物
CN1192773C (zh) 环胺ccr3拮抗剂
CN1585749A (zh) 类大麻苷受体配体
CN1764454A (zh) 蛋白酪氨酸激酶的环状抑制剂
CN1033380A (zh) 化合物
CN1039809A (zh) 取代的氨甲基四氢化萘及其杂环同系物的制备
CN1391564A (zh) 化合物
CN1890218A (zh) 微管蛋白抑制剂
CN87101285A (zh) 8-取代的-2-氨基-1，2，3，4-四氢化荼
CN1119099A (zh) 对中枢神经系统具有药理活性的药物组合物的制备方法
CN1130345C (zh) 氨基喹啉衍生物
CN1642927A (zh) 环状酰胺
CN1829694A (zh) 喹啉衍生物和它们在治疗中的用途
CN1509184A (zh) 止痒剂
CN1086819A (zh) 有5-羟色胺受体拮抗活性的新化合物
CN1639121A (zh) 具有鸦片样受体亲合性的3－氮杂二环并(3.1.0)己烷衍生物
CN1019388B (zh) 新型n-烷磺酰苯胺衍生物的制备方法
CN1254334A (zh) 新颖的对苯二甲酰胺衍生物
CN85108618A (zh) 苯稠杂环化合物的制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee